TGFB1 and experimental autoimmune encephalomyelitis: Several studies have demonstrated that CD4+LAP+ T cells suppress diseases such as colitis, lupus, atherosclerosis and experimental autoimmune encephalomyelitis (EAE) in animal models14–17.